Hepatitis C virus differentially modulates activation of Forkhead transcription factors and insulin-induced metabolic gene expression

Journal of Virology

Volumn 84, Issue 12, 2010, Pages 5936-5946

  Banerjee, Arup ^a   Meyer, Keith ^a   Mazumdar, Budhaditya ^a   Ray, Ratna B ^a   Ray, Ranjit ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CORE PROTEIN; GLUCOSE 6 PHOSPHATASE; HEPATOCYTE NUCLEAR FACTOR 3BETA; INSULIN; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; POLYPROTEIN; PROTEIN 14 3 3; PROTEIN KINASE B; SERINE; TRANSCRIPTION FACTOR FKHR; VIRUS PROTEIN;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; VIRUS GENOME;

14-3-3 PROTEINS; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATITIS C; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HEPATOCYTES; HUMANS; INSULIN; PHOSPHORYLATION;

HEPATITIS C VIRUS;

EID: 77952708205     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02344-09     Document Type: Article

References (43)

1. Adinolfi, L. E., M. Gambardella, A. Andreana, M. F. Tripodi, R. Utili, and G. Ruggiero. 2001. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33:1358-1364.
2. Ait-Goughoulte, M., T. Kanda, K. Meyer, J. S. Ryerse, R. B. Ray, and R. Ray. 2008. Hepatitis C virus genotype 1a growth and induction of autophagy. J. Virol. 82:2241-2249. (Pubitemid 351293524)
3. Altomonte, J., A. Richter, S. Harbaran, J. Suriawinata, J. Nakae, S. N. Thung, M. Meseck, D. Accili, and H. Dong. 2003. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am. J. Physiol. Endocrinol. Metab. 285:E718-E728.
4. Aoki, H., J. Hayashi, M. Moriyama, Y. Arakawa, and O. Hino. 2000. Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J. Virol. 74:1736-1741. (Pubitemid 30434030)
5. Asselah, T., L. Rubbia-Brandt, P. Marcellin, and F. Negro. 2006. Steatosis in chronic hepatitis C: why does it really matter? Gut 55:123-130.
6. Au, W. S., H. F. Kung, and M. C. Lin. 2003. Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAP-Kerk and MAPKp38. Diabetes 52:1073-1080.
7. Banerjee, S., K. Saito, M. Ait-Goughoulte, K. Meyer, R. B. Ray, and R. Ray. 2008. Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance. J. Virol. 82:2606-2612. (Pubitemid 351329151)
8. Basu, A., K. Meyer, R. B. Ray, and R. Ray. 2002. Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes. Virology 298:53-62. (Pubitemid 34734879)
9. Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-869.
10. Castéra, L., C. Hézode, F. Roudot-Thoraval, A. Bastie, E. S. Zafrani, J. M. Pawlotsky, and D. Dhumeaux. 2003. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 52:288-292. (Pubitemid 36115074)
11. Chang, K. S., J. Jiang, Z. Cai, and G. Luo. 2007. Human apolipoprotein E is required for infectivity and production of hepatitis C virus in cell culture. J. Virol. 81:13783-13793.
12. Gastaminza, P., G. Cheng, S. Wieland, J. Zhong, W. Liao, and F. V. Chisari. 2008. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J. Virol. 82:2120-2129. (Pubitemid 351293514)
13. Gross, D. N., A. P. van den Heuvel, and M. J. Birnbaum. 2008. The role of FoxO in the regulation of metabolism. Oncogene 27:2320-2336.
14. Han, E. K., J. D. Leverson, T. McGonigal, O. J. Shah, K. W. Woods, T. Hunter, V. L. Giranda, and Y. Luo. 2007. Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition. Oncogene 26:5655-5661.
15. Huang, H., and D. J. Tindall. 2007. Dynamic FoxO transcription factors. J. Cell Sci. 120:2479-2487.
16. Huang, H., F. Sun, D. M. Owen, W. Li, Y. Chen, M. Gale, Jr., and J. Ye. 2007. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 104:5848-5853.
17. Jiang, J., and G. Luo. 2009. Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. J. Virol. 83:12680-12691.
18. Kamagate, A., S. Qu, G. Perdomo, D. Su, D. H. Kim, S. Slusher, M. Meseck, and H. H. Dong. 2008. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J. Clin. Invest. 118:2347-2364.
19. Kanda, T., A. Basu, R. Steele, T. Wakita, J. S. Ryerse, R. Ray, and R. B. Ray. 2006. Generation of infectious hepatitis C virus in immortalized human hepatocytes. J. Virol. 80:4633-4639.
20. Kino, T., M. U. De Martino, E. Charmandari, T. Ichijo, T. Outas, and G. P. Chrousos. 2005. HIV-1 accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of forkhead transcription factors by interfering with their binding to 14-3-3 proteins: potential clinical implications regarding the insulin resistance of HIV-1-infected patients. Diabetes 54:23-31. (Pubitemid 40105091)
21. Kondapaka, S. B., M. Zarnowski, D. R. Yver, E. A. Sausville, and S. W. Cushman. 2004. 7-hydroxystaurosporine (UCN-01) inhibition of Akt Thr308 but not Ser473 phosphorylation: a basis for decreased insulin-stimulated glucose transport. Clin. Cancer Res. 10:7192-7198.
22. Lee, S. K., S. O. Park, C. O. Joe, and Y. S. Kim. 2007. Interaction of HCV core protein with 14-3-3ε protein releases Bax to activate apoptosis. Biochem. Biophy. Res. Commun. 352:756-762.
23. Manning, B. D., and L. C. Cantley. 2007. AKT/PKB signaling: navigating downstream. Cell 129:1261-1274.
24. Matsumoto, M., S. Han, T. Kitamura, and D. Accili. 2006. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J. Clin. Invest. 116:2464-2472.
25. Mirandola, S., S. Realdon, J. Iqbal, M. Gerotto, F. Dal Pero, G. Bortoletto, M. Marcolongo, A. Vario, C. Datz, M. M. Hussain, and A. Alberti. 2006. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver Steatosis. Gastroenterology 130:1661-1669. (Pubitemid 43668848)
26. Monazahian, M., I. Böhme, S. Bonk, A. Koch, C. Scholz, S. Grethe, and R. Thomssen. 1999. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 57:223-229.
27. Nakae, J., T. Kitamura, D. L. Silver, and D. Accili. 2001. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108:1359-1367.
28. Ohata, K., K. Hamasaki, K. Toriyama, K. Matsumoto, A. Saeki, K. Yanagi, S. Abiru, Y. Nakagawa, M. Shigeno, S. Miyazoe, T. Ichikawa, H. Ishikawa, K. Nakao, and K. Eguchi. 2003. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 97:3036-3043. (Pubitemid 36676258)
29. Owen, D. M., H. Huang, J. Ye, and M. Gale, Jr. 2009. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. Virology 394:99-108.
30. Perlemuter, G., A. Sabile, P. Letteron, G. Vona, A. Topilco, Y. Chrétien, K. Koike, D. Pessayre, J. Chapman, G. Barba, and C. Bréchot. 2002. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J. 16:185-194. (Pubitemid 34113012)
31. Petit, J. M., M. Benichou, L. Duvillard, V. Jooste, J. B. Bour, A. Minello, B. Verges, J. M. Brun, P. Gambert, and P. Hillon. 2003. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis. Am. J. Gastroenterol. 98:1150-1154.
32. Puigserver, P., J. Rhee, J. Donovan, C. J. Walkey, J. C. Yoon, F. Oriente, Y. Kitamura, J. Altomonte, H. Dong, D. Accili, and B. M. Spiegelman. 2003. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423:550-555. (Pubitemid 36648580)
33. Ray, R. B., K. Meyer, and R. Ray. 2000. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology 271:197-204.
34. Samuel, V. T., C. S. Choi, T. G. Phillips, A. J. Romanelli, J. G. Geisler, S. Bhanot, R. McKay, B. Monia, J. R. Shutter, R. A. Lindberg, G. I. Shulman, and M. M. Veniant. 2006. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 55:2042-2050.
35. Sato, S., N. Fujita, and T. Tsuruo. 2002. Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine). Oncogene 21: 1727-1738. (Pubitemid 34259036)
36. Serfaty, L., T. Andreani, P. Giral, N. Carbonell, O. Chazouillè res, and R. Poupon. 2001. Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J. Hepatol. 34:428-434. (Pubitemid 32240823)
37. Su, A. I., J. P. Pezacki, L. Wodicka, A. D. Brideau, L. Supekova, R. Thimme, S. Wieland, J. Bukh, R. H. Purcell, P. G. Schultz, and F. V. Chisari. 2002. Genomic analysis of the host response to hepatitis C virus infection. Proc. Natl. Acad. Sci. U. S. A. 99:15669-15674.
38. Tazawa, J., M. Maeda, M. Nakagawa, H. Ohbayashi, F. Kusano, M. Yamane, Y. Sakai, and K. Suzuki. 2002. Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig. Dis. Sci. 47:710-715.
39. Tsai, W. C., N. Bhattacharyya, L. Y. Han, J. A. Hanover, and M. M. Rechler. 2003. Insulin inhibition of transcription stimulated by the forkhead protein Foxo1 is not solely due to nuclear exclusion. Endocrinology 144:5615-5622.
40. Virkamäki, A., K. Ueki, and C. R. Kahn. 1999. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest. 103:931-943.
41. Wolfrum, C., and M. Stoffel. 2006. Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion. Cell Metab. 3:99-110.
42. Wolfrum, C., E. Asilmaz, E. Luca, J. M. Friedman, and M. Stoffel. 2004. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432:1027-1032. (Pubitemid 40052233)
43. Zhao, X., L. Gan, H. Pan, D. Kan, M. Majeski, S. A. Adam, and T. G. Unterman. 2004. Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. Biochem. J. 378:839-849. (Pubitemid 38406861)